Knight Capital Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Knight Capital Group’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$32K	Buy	+3,626	New	+$38K	﹤0.01%	3120

Other funds holding CDMO

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

QBFM

QS Batterymarch Financial Management New York $3.78B AUM 22.02% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Knight Capital Group's CDMO Position: Q2 2013 in Review

Knight Capital Group opened a new position in Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2013: 3,626 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #3120 among its holdings.

69 funds tracked by Wall St. Rank hold CDMO as of Q2 2013.

Knight Capital Group held 3,626 shares of Avid Bioservices, Inc. Common Stock worth $32K as of Q2 2013.
Avid Bioservices, Inc. Common Stock was a new Knight Capital Group position in Q2 2013.
Avid Bioservices, Inc. Common Stock made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3120 holding.
69 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.